Cite

    David Foureau et al.. “Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma.” Cancer medicine, vol. 10, 2021, pp. 6933–6936. http://access.bl.uk/ark:/81055/vdc_100144507933.0x000007